Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 2 years ago

Possible Interaction: Arginine and Cyclosporine

supplement:

Arginine

Research Papers that Mention the Interaction

Animal studies have shown that dietary supplementation with arginine and lipids containing the &ohgr;-3 and &ohgr;-9 fatty acids prolong allograft survival in animals receiving a short course of low-dose cyclosporine.
Transplantation  •  2005  |  View Paper
Also, the acute glucagon response to arginine during hyperglycemia declined less in the FK-506 (28%) and CsA groups (29%) compared with controls (48%) (P<0.05) indicating a defect in the pancreatic beta cell-alpha cell axis.
The lower percentage of increase of insulin release after arginine stimulation observed in the FK-506 and CsA groups as compared with controls (754%+/-100, 644%+/-102 vs. 1191%+/-174) (P<0.03 and 0.02, respectively), suggests a reduced beta cell secretory reserve in both treated groups.
Transplantation  •  1999  |  View Paper
In contrast, administration of l-Arg ameliorated the effect of CsA on H+ excretion.
Journal of Pharmacology and Experimental Therapeutics  •  2003  |  View Paper
More infiltrating inflammatory cells were detected at an early stage of tumor rejection in rats treated with arginine plus cyclosporine than in cyclosporine-treated rats.
The antagonistic effect between arginine and cyclosporine on immune suppression is worthy of further investigation in organ transplant patients.
In vivo  •  2001  |  View Paper
The supplement of L-arginine (1 mM) promoted NO production that enhanced EPC proliferation and attenuated the effect of CsA on EPC proliferation and apoptosis.
Internal medicine  •  2008  |  View Paper
In this study we investigated whether the PPARgamma ligand rosiglitazone R ) enhances in vitro the immunosuppressive effects of cyclosporine A (CsA).
Low-dose CsA combined with R was significantly more powerful than either high-dose CsA alone or R alone in suppressing IL-2 release, arresting the T cell cycle, and blocking the growth of activated T cells.
Transplant immunology  •  2007  |  View Paper
The L65R(TM1), T199R(TM3), I306R(TM5), or F343R(TM6) mutations were introduced into the P-gp mutant L339C(… carried out in the presence of various concentrations of vinblastine, cyclosporin A, or rhodamine B. The presence of arginine residues reduced the …, T199R, and I306R), cyclosporin (I306R and …–60-fold.
Journal of Biological Chemistry  •  2007  |  View Paper
Furthermore, the observed increase in sodium excretion could indicate that L-arginine counteracts the antinatriuretic effect of cyclosporin.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association  •  1997  |  View Paper
Furthermore, l-arginine pretreatment with cyclosporine A (5 mg/kg) significantly reversed the protective effect of cyclosporine A. However, l-nitro-arginine methyl ester (l-NAME; 10 mg/kg) pretreatment potentiated the protective effect of cyclosporine A (5 mg/kg).
International journal of toxicology  •  2010  |  View Paper
Coadministration of trapidil + l-arginine significantly ameliorated the toxic effect of CsA , but did not differ significantly from the effect of trapidil alone.
Renal failure  •  2010  |  View Paper
Show More